MAPK9 and glaucoma: On the other side of the spectrum, haploinsufficiency of JNK2, or both JNK2 and JNK3, results in an increase in ocular hypertension-induced neurodegeneration, suggesting JNK2 as a potential tool for glaucoma treatment [130].